Results 31 to 40 of about 1,047 (134)
Tumefactive multiple sclerosis in Taiwan. [PDF]
PLoS ONE, 2013 BACKGROUND: Multiple sclerosis (MS) is less common in Asia, including Taiwan, and some characteristics of MS in Asians differ from those of Caucasians. Tumefactive brain lesion is even rarer in MS patients.
Yi-Chun Kuan +3 more
doaj +1 more source
Tumefactive: A Rare First presentation of Multiple Sclerosis [PDF]
Disease and Diagnosis, 2018 Tumefactive demyelinating lesions are a rare presentation of multiple sclerosis (MS). Diagnosis of tumefactive is commonly carried out using magnetic resonance image (MRI). Tumefactive diagnosis is difficult because of may similar to the clinical and MRI
Athena Sharifi Razavi +3 more
doaj +1 more source
Multifocal Tumefactive Demyelination Mimicking Intracranial Neoplasm [PDF]
Journal of Clinical and Diagnostic Research, 2016 Demyelinating disease presenting with clinical and radiologic features similar to a brain tumour is referred to as tumefactive demyelination. These lesions pose considerable diagnostic uncertainty.
Tom George +3 more
doaj +1 more source
Tumefactive demyelinating lesion
Journal of Postgraduate Medicine, 2010 Tumefactive demyelinating lesion, a variant of multiple sclerosis, is a solitary large demyelinating lesion, which mimics cerebral neoplasm. Distinguishing tumefactive lesions from other etiologies of intracranial space-occupying lesions is essential to avoid inadvertent surgical or toxic chemotherapeutic interventions.
Sinha, M. K. +3 more
openaire +3 more sources
Longitudinal Brain Atrophy Patterns in Early MOG-Antibody Associated Disease and Relapsing Multiple Sclerosis. [PDF]
Eur J NeurolABSTRACT Background Myelin oligodendrocyte glycoprotein antibody‐associated disease can manifest as a relapsing or monophasic condition. Although several MRI studies have shown evident gray and white matter atrophy compared to healthy controls, little is known about regional brain volume dynamics in myelin oligodendrocyte glycoprotein antibody ...
Ladopoulos T +10 more
europepmc +2 more sources
Frontiers in Neurology, 2020 Atypical forms of demyelinating diseases with tumor-like lesions and aggressive course represent a diagnostic and therapeutic challenge for neurologists.
Aigli G. Vakrakou +14 more
doaj +1 more source
Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge
Case Reports in Radiology, 2012 Tumefactive demyelinating lesion is defined as large solitary demyelinating lesion with imaging characteristics mimicking neoplasm. These atypical features include size more than 2 cm, mass effect, edema, and/or ring enhancement.
Hossein Kalanie +3 more
doaj +1 more source
Diagnostics, 2020 Magnetic-resonance (MR) imaging is the modality of choice for the evaluation of spinal-cord lesions. However, challenges persist in discriminating demyelinating processes from neoplastic lesions using conventional MR sequences.
Yung Hsu +5 more
doaj +1 more source
Tumefactive multiple sclerosis masquerade as a central nervous system tumor: a case report
Electronic Physician, 2018 Introduction: Tumefactive multiple sclerosis is a demyelinating disorder that appears tumor-like on MRI. To most physicians, diagnosing tumefactive MS by applying clinical, radiological, or laboratory examination like Cerebrospinal fluid (CSF) analysis,
Alaa Nabil Turkistani +3 more
doaj +1 more source
Fulminant inflammatory demyelination presenting as stroke‐in‐evolution in an elderly subject
Brain and Behavior, 2021 Background Fulminant inflammatory demyelination is a possible presentation of inflammatory demyelinating disorders, thus representing a potential stroke mimic especially in younger patients.
Simone Sacco +8 more
doaj +1 more source